Trial Profile
A Phase I, Open-Label Study of NC-6004 in Combination with Gemcitabine in Japanese Patients with Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 03 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology